Exchange: NYSEMkt·Updated 05:31 AM EDT
MTNB logo

MTNB Matinas Biopharma Holdings Inc

$0.1856
$0.0006
(0.32%)
Pre-Market
Prev Close $0.185
Reported EarningsNov 6
Mkt Cap$2.72M
Vol17,519.00

About MTNB

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.
37

Bearish Sentiment

How do you feel about MTNB?

Advertisement|Remove ads.